MedPath

Life Without Diabetes

Not Applicable
Completed
Conditions
Prevention of Developing Type 2 Diabetes
Interventions
Behavioral: Increased daily activity detected by the pedometer
Behavioral: Increased daily activity detected by the pedometer+group intervention
Behavioral: High intense interval training
Behavioral: Increased daily activity detected by the pedometer+HIIT
Registration Number
NCT02212665
Lead Sponsor
University Hospital, Gentofte, Copenhagen
Brief Summary

The aim of the study 'Live - without diabetes' is to investigate the effects of increased physical activity on a daily basis with or without (high intense interval training) HIIT (short and intense: 3 minutes per week) during 12 weeks in risk individuals with pre-diabetes

Detailed Description

A total of 125 individuals with pre-diabetes will be included and randomized into four different groups (N=25, each group): 1) Increased daily activity detected by the pedometer, 2) increased daily activity detected by the pedometer + HIIT, 3) HIIT, and 4) increased daily activity detected by the pedometer + group intervention 5) a control group (maintain unchanged activity and life-style during the duration of the study).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Body mass index (BMI) > 25 kg/m2
  • Prediabetes: 6.1 % ≤ glycated hemoglobin A1c (HbA1c) ≤ 6.4 % and / or increased fasting plasma glucose (FPG): 6.1 mM ≤ FPG ≤ 6.9 mM and / or abnormal glucose tolerance (7.8 mM ≤ 2 hour plasma glucose (PG) ≤ 11.0 mmol)
  • Weekly training status <150 minutes
Exclusion Criteria
  • BMI <25 kg/m2
  • Diabetes
  • Pregnancy and breastfeeding
  • Treatment with medicine, there influence glucose metabolism
  • Decreased liver function (liver transaminases > 3 times of limit of normal)

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Arm && Interventions
GroupInterventionDescription
Increased daily activity detected by the pedometerIncreased daily activity detected by the pedometer10.000 steps a day
Increased daily activity (pedometer)+group interventionIncreased daily activity detected by the pedometer+group intervention10.000 steps + group intervention
High intense interval training (HIIT)High intense interval training3 x 20 sec, 3 x week
Increased daily activity detected by te pedometer+HIITIncreased daily activity detected by the pedometer+HIIT10.000 steps + 3 x 20 sec, 3 x week
Primary Outcome Measures
NameTimeMethod
Changes in insulin sensitivityAt baseline and after 12 weeks

The primary endpoint is insulin sensitivity, and it will be assessed by changes in the area under the curve from baseline to end-of-study assessed by the Cederholm Index and Matsuda Index

Secondary Outcome Measures
NameTimeMethod
Patient-reported outcome measureAt baseline and after 12 weeks

Health related quality of life measured from Short Form 36 (SF36). Where scores are presented as norm-based scores (0-100) with higher scores indicating better perceived health status.

Changes in key proteins in glucose and fat metabolism (Adipose fat tissure)At baseline and after 12 weeks

Expression/content of key proteins in adipose tissue (AU units)

Changes in key proteins in glucose and fat metabolism (Skeletal muscle)At baseline and after 12 weeks

Expression/content of key proteins in skeletal muscle tissure (AU units)

Changes in body weight (kg)At baseline and after 12 weeks

Measured by Dual-energy X-ray Absorptiometry, DXA

Changes in oxygen peak oxygen uptakeAt baseline and after 12 weeks

Assessed from a physical fitness test (VO2peak)

Changes in glycaemic controlAt baseline and after 12 weeks

Measured as fasting plasma glucose, HbA1c

Trial Locations

Locations (1)

Center for Diabetes Research, Gentofte Hospital

🇩🇰

Hellerup, Denmark

© Copyright 2025. All Rights Reserved by MedPath